Research also suggests liraglutide may help support beta-cell function, which plays a key role in ongoing insulin production and metabolic balance
In September 2025, the FDA issued a warning letter to Novo Nordisk, the manufacturer of Ozempic, concerning promotional communications that were found to be "false or misleading" because they failed to adequately present the serious risks of these drugs, including their boxed warning for thyroid C-cell tumors and other significant risks like pancreatitis
C.WhitmanW
People who treat GLP-1 therapy as a window of opportunity, using the appetite suppression to build better habits rather than just eating less of the same foods, are the ones who maintain their results when the medication dose decreases or stops
Increased Energy Many clients report feeling more refreshed, energized, and focused after treatment
Semaglutide slows gastric emptying, but this typically does not meaningfully reduce levothyroxine absorption when doses are properly spaced
